Skip to content

Different Techniques for Perineal Skin Closure During Mediolateral Episiotomy Repair

Comparison of Different Techniques for Perineal Skin Closure During Mediolateral Episiotomy Repair

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03780530
Enrollment
207
Registered
2018-12-19
Start date
2019-01-01
Completion date
2019-12-01
Last updated
2018-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Episiotomy

Brief summary

this study aims to assess the efficacy and the safety of various cosmetic techniques (subcuticular, surgical glue, adhesive tapes) for perineal skin closure during mediolateral episiotomy repair

Interventions

Those undergoing Subcuticular suturing of perineal skin using 910 polyglactin vicryl No 2/0 (EGYCRYL®).

PROCEDURESurgical glue

Those undergoing perineal skin closure using adhesive glue n-butyl-2-cyanoacrylate (Histoacryl®).

PROCEDUREadhesive steri-strip tape

Those undergoing closure of perineal skin via Adhesive surgical water-resistant tape application. (3M® Transpore™ Surgical Tapes).

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Women aged above 18 yrs. * Primiparous. * Undergoing spontaneous vaginal delivery of a single full-term fetus. * Vertex presentation. * Having mediolateral episiotomy.

Exclusion criteria

* Body mass index ≥ 35 kg/m2 * Complicated delivery by any tears other than episiotomy or postpartum hemorrhage. * Any risk factor causing increased stretch of the perineum; Operative vaginal delivery, fetal macrosomia. * The use of epidural anesthesia. * Previous perineal surgeries, local infection or lesions. * Any medical condition that can cause excessive bleeding or impair wound healing; (cardiovascular disease, diabetes, anemia, coagulopathy, collagen disease or Immunosuppression). * Contraindication or Hypersensitivity to any of materials used in the study.

Design outcomes

Primary

MeasureTime frameDescription
Short -term postpartum painsix hours postpartumPost-operative perineal pain will be evaluated at 6 hrs after the procedure using visual analogue scale patient to choose a number from 0 to 10 that best describes their current pain. 0 would mean no pain and 10 would mean worst possible pain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026